Post-approval studies (Phase 4)WithdrawnNCT02558361What this trial is testingTreatment With Apremilast in Patients With Psoriatic ArthritisWho this might be right forPsoriatic Arthritis University of South Florida
Large-scale testing (Phase 3)Study completedNCT02181673What this trial is testingGolimumab in Participants With Active Psoriatic ArthritisWho this might be right forArthritis, Psoriatic Janssen Research & Development, LLC 480
Testing effectiveness (Phase 2)Looking for participantsNCT07801495What this trial is testingAssess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic ArthritisWho this might be right forModerate to Severe Psoriatic Arthritis Novartis Pharmaceuticals 220
Early research (Phase 1)Study completedNCT02141763What this trial is testingMultiple Dose Study of UCB4940 in Subjects With Psoriatic ArthritisWho this might be right forPsoriatic Arthritis UCB Celltech 53
Not applicableStudy completedNCT03173144What this trial is testingChronic Inflammatory Disease, Lifestyle and Treatment ResponseWho this might be right forAutoimmune DiseasesInflammatory Bowel DiseasesCrohn Disease (CD)+7 more University of Southern Denmark 233
Not applicableEnded earlyNCT02775656What this trial is testingUCB Cimzia Pregnancy Follow-up StudyWho this might be right forRheumatoid Arthritis (RA)Crohn's Disease (CD)Psoriatic Arthritis (PsA)+1 more UCB BIOSCIENCES, Inc. 1
Testing effectiveness (Phase 2)Ended earlyNCT02429895What this trial is testingA Phase 2, Multicenter Open-Label Extension (OLE) Study With ABT-122 in Active Psoriatic Arthritis Subjects Who Have Completed a Preceding Study M14-197Who this might be right forPsoriatic Arthritis AbbVie 168
Not applicableStudy completedNCT01818804What this trial is testingThe Effect of n-3 Polyunsaturated Fatty Acids in Patients With Psoriatic ArthritisWho this might be right forPsoriatic Arthritis Aalborg University Hospital 145
Not applicableLooking for participantsNCT06630715What this trial is testingEfficacy Of Upadacitinib In Psoriatic Arthritis And Comparison To Rheumatoid Arthritis.Who this might be right forRheumatoid Arthritis (RAPsoriatic Arthritis (PsA I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio 178
Large-scale testing (Phase 3)Study completedNCT03769168What this trial is testingAn Extension Study of Subcutaneous Secukinumab in Patients With Juvenile Psoriatic Arthritis (JPsA) and Enthesitis Related Arthritis (ERA)Who this might be right forJuvenile Psoriatic ArthritisEnthesitis Related Arthritis Novartis Pharmaceuticals 55
Large-scale testing (Phase 3)Study completedNCT04009499What this trial is testingAssess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic ArthritisWho this might be right forPsoriatic Arthritis UCB Biopharma SRL 1,131
Not applicableStudy completedNCT04277832What this trial is testingEvaluating of New Screening Tool for Arthritis* in PsoriasisWho this might be right forPsoriasisPsoriatic Arthritis Bezmialem Vakif University 200
Post-approval studies (Phase 4)Looking for participantsNCT07141004What this trial is testingGuselkumab Administered Subcutaneously in Treatment of Indian Participants With Psoriatic Arthritis (PsA)Who this might be right forArthritis, Psoriatic Johnson & Johnson Private Limited 100
Testing effectiveness (Phase 2)Study completedNCT00001422What this trial is testingA Controlled Trial of Intermittent Fludarabine for Psoriatic ArthritisWho this might be right forArthritis, PsoriaticPsoriasis National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 20
Not applicableEnrolling By InvitationNCT01402661What this trial is testingCorEvitas Rheumatoid Arthritis (RA) Drug Safety & Effectiveness RegistryWho this might be right forRheumatoid Arthritis CorEvitas 91,758
Large-scale testing (Phase 3)Study completedNCT04209205What this trial is testingStudy to Demonstrate the Efficacy, Safety and Tolerability of Intravenous Secukinumab up to 52 Weeks in Subjects With Active Psoriatic ArthritisWho this might be right forPsoriatic Arthritis Novartis Pharmaceuticals 381
Not applicableStudy completedNCT03608657What this trial is testingStudy to Evaluate the Real-World Effectiveness, Safety and Tolerability of Treatment With Apremilast in Psoriatic Arthritis Patients Followed in Canadian Routine Care (APPRAISE)Who this might be right forArthritis, Psoriatic Amgen 102
Not applicableNot Yet RecruitingNCT07793773What this trial is testingDisease Impact and Its Correlation With Disease Activity in Psoriatic ArthritisWho this might be right forPsoriatic Arthritis Assiut University 80
Post-approval studies (Phase 4)Study completedNCT03151551What this trial is testingIxekizumab (LY2439821) Versus Adalimumab in Participants With Psoriatic ArthritisWho this might be right forPsoriatic Arthritis Eli Lilly and Company 566
Not applicableStudy completedNCT03106051What this trial is testingStudy of Apremilast Use in Patients With Psoriatic Arthritic in Practice ConditionsWho this might be right forArthritis, Psoriatic Amgen 526